These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2608893)

  • 1. [Changes in the redox potential of serum samples following in vitro irradiation--an indicator of malignant tumor growth].
    Hamann D; Heinrich H
    Radiobiol Radiother (Berl); 1989; 30(6):527-34. PubMed ID: 2608893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes in redox potentials in serum samples as affected by adenosine triphosphate].
    Heinrich H; Hamann D
    Radiobiol Radiother (Berl); 1990; 31(3):239-42. PubMed ID: 2385746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.
    Kraft A; Weindel K; Ochs A; Marth C; Zmija J; Schumacher P; Unger C; Marmé D; Gastl G
    Cancer; 1999 Jan; 85(1):178-87. PubMed ID: 9921991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of the O6-methylguanine-DNA methyltransferase and glutathione S-transferase activity in the sera of patients with malignant and benign ovarian tumors.
    Akçay T; Dinçer Y; Alademir Z; Aydinli K; Arvas M; Demirkiran F; Kösebay D
    Eur J Obstet Gynecol Reprod Biol; 2005 Mar; 119(1):108-13. PubMed ID: 15734094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study of serum levels of magnesium in the patients with malignant tumors].
    Varazashvili Varazi LM; Osmanova VR; Barkadze KI
    Georgian Med News; 2006 Jul; (136):35-9. PubMed ID: 16905841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of UV-irradiation on human serum under normal and pathologic conditions].
    Kulikov VIu; Kaznacheev VP; Kolesnikova LI
    Biull Eksp Biol Med; 1977 Apr; 83(4):427-9. PubMed ID: 857969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superoxide dismutases in malignant cells and human tumors.
    Kinnula VL; Crapo JD
    Free Radic Biol Med; 2004 Mar; 36(6):718-44. PubMed ID: 14990352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostic value of total and lipid-bound sialic acid in malignancies].
    Cylwik B; Chrostek L; Szmitkowski M
    Pol Merkur Lekarski; 2005 Aug; 19(110):237-41. PubMed ID: 16245443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TP53 alterations as a potential diagnostic marker in superficial bladder carcinoma and in patients serum, plasma and urine samples.
    Dahse R; Utting M; Werner W; Schimmel B; Claussen U; Junker K
    Int J Oncol; 2002 Jan; 20(1):107-15. PubMed ID: 11743649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
    Ulbright TM
    Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of serine and glutamine in the metabolism of malignant bone tumors and their significance in the diagnosis and prognosis of bone tumors.
    Mäsiar PJ; Medeková E
    Neoplasma; 1988; 35(2):197-206. PubMed ID: 3131689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marker for renal cell carcinoma (RCC): the dimeric form of pyruvate kinase type M2 (Tu M2-PK).
    Wechsel HW; Petri E; Bichler KH; Feil G
    Anticancer Res; 1999; 19(4A):2583-90. PubMed ID: 10470199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Ape-1/Ref-1 redox antagonist E3330 inhibits the growth of tumor endothelium and endothelial progenitor cells: therapeutic implications in tumor angiogenesis.
    Zou GM; Karikari C; Kabe Y; Handa H; Anders RA; Maitra A
    J Cell Physiol; 2009 Apr; 219(1):209-18. PubMed ID: 19097035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue polypeptide-specific antigen (TPS) in pediatric malignancies.
    Rebhandl W; Paya K; Felberbauer FX; Fuchs R; Henkel J; Bieglmayer C; Horcher E
    Anticancer Res; 1997; 17(4B):2865-8. PubMed ID: 9329549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of sera of breast cancer patients on NK cell activity].
    Konjević G; Spuzić I
    Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concentration of vascular endothelial growth factor (VEGF) in the serum of patients with malignant bone tumors.
    Holzer G; Obermair A; Koschat M; Preyer O; Kotz R; Trieb K
    Med Pediatr Oncol; 2001 Jun; 36(6):601-4. PubMed ID: 11344490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased levels of a 21-kDa protein in the circulation of tumor-bearing patients.
    Shalitin C; Epelbaum R; Moskovitz B; Segal R; Valansi C; Werner M; Livne PM
    Cancer Detect Prev; 1994; 18(5):357-65. PubMed ID: 7812982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CA 19-9 is an index of response to neoadjunctive chemoradiation therapy in pancreatic cancer.
    Willett CG; Daly WJ; Warshaw AL
    Am J Surg; 1996 Oct; 172(4):350-2. PubMed ID: 8873528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor.
    Salven P; Orpana A; Joensuu H
    Clin Cancer Res; 1999 Mar; 5(3):487-91. PubMed ID: 10100697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 'Sentinel Node' Concept: More Questions Raised than Answers Provided?
    Schlag PM
    Oncologist; 1998; 3(5):VI-VII. PubMed ID: 10388128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.